Frontlight ResearchEarly access
What researchers published on Macular degeneration
13,668 papers, newest first.
Showing 20 of 651
Trial resultFirst-in-Human Regulatory T Cell-Derived Exosomes Plus Ranibizumab for Refractory nAMD.Journal of extracellular vesicles
In plain wordsRead moreRead the paper on PubMedRandomised trialThe Effect of Resveratrol, Quercetin, and Curcumin on Drusen Volume in Age-Related Macular Degeneration: A Randomized Clinical Trial.Translational vision science & technology
In plain wordsRead moreRead the paper on PubMedRandomised trialEffect of a mobile application-based whole-course nutrition management intervention in patients with age-related macular degeneration: a randomized controlled trial.Frontiers in public health
In plain wordsRead moreRead the paper on PubMedRandomised trialShort-term adjunctive use of a liposomal tear substitute after repeated intravitreal therapy: a randomized pilot study.International ophthalmology
In plain wordsRead moreRead the paper on PubMedRandomised trialLongitudinal Prediction of Retinal Sensitivity Based on Disease Progression Quantified From Optical Coherence Tomography in Geographic Atrophy.Investigative ophthalmology & visual science
In plain wordsRead moreRead the paper on PubMedRandomised trialCost-Effectiveness of Photobiomodulation for Intermediate Dry Age-Related Macular Degeneration: A Model-Based Analysis Using the LIGHTSITE III 24-Month Trial.American journal of ophthalmology
In plain wordsRead moreRead the paper on PubMedRandomised trialIncomplete Retinal Pigment Epithelium and Outer Retinal Atrophy Characterized Using Fundus Autofluorescence: An 18-Month Post Hoc Analysis of GATHER2.Investigative ophthalmology & visual science
In plain wordsRead moreRead the paper on PubMedRandomised trialEQ-5D vision bolt-on in macular degeneration: associations with visual measures and effect on utility differences and cost-effectiveness of stereotactic radiotherapy.Health and quality of life outcomes
In plain wordsRead moreRead the paper on PubMedTrial resultArtificial Intelligence-Assisted Screening for Patients With Diabetic Retinopathy and Age-Related Macular Degeneration in Family Medicine and Geriatric and Gerontology Care: Protocol for a Pragmatic Randomized Clinical Trial.JMIR research protocols
Randomised trialEffect of Key Baseline Disease Characteristics on Aflibercept 8 mg Dosing Interval Extension: A Post Hoc 96-Week Analysis of PULSAR.Ophthalmology. Retina
In plain wordsRead moreRead the paper on PubMedRandomised trialAvacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation and Loss in Eyes with Geographic Atrophy.Ophthalmology
In plain wordsRead moreRead the paper on PubMedRandomised trialStereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR).BMJ (Clinical research ed.)
In plain wordsRead moreRead the paper on PubMedRandomised trialCommunity Optometrist-Led Monitoring of Quiescent Neovascular Age-Related Macular Degeneration: The FENETRE Randomized Clinical Trial.JAMA network open
In plain wordsRead moreRead the paper on PubMedTrial resultSubretinal rAAV2-based VEGF-Trap gene therapy for neovascular age-related macular degeneration: Preclinical assessment and phase 1 trial results.Cell reports. Medicine
In plain wordsRead moreRead the paper on PubMedRandomised trialGildeuretinol Acetate versus Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration: The Study of ALK-001 in Geographic Atrophy Randomized Clinical Trial.Ophthalmology. Retina
In plain wordsRead moreRead the paper on PubMedTrial resultWT1-pulsed dendritic cell vaccination for neovascular age-related macular degeneration: a phase I pilot feasibility study.BMC ophthalmology
In plain wordsRead moreRead the paper on PubMedTrial resultI-SCREEN: Development of an AI-based infrastructure for community-wide screening and prediction of progression in age-related macular degeneration providing accessible shared care.Eye (London, England)
Randomised trialVision-Related Quality of Life in Geographic Atrophy: Association with Topographic Lesion Distribution.Ophthalmology
In plain wordsRead moreRead the paper on PubMedRandomised trialAssociation between screening duration and treatment outcomes in the clinical trials of ranibizumab and aflibercept for neovascular age-related macular degeneration.Scientific reports
In plain wordsRead moreRead the paper on PubMedRandomised trialPULSAR: Clinical Outcomes of Aflibercept 8 mg with Extended Dosing and 2 mg in Neovascular Age-Related Macular Degeneration in Subgroups Defined by Baseline Characteristics.Ophthalmology. Retina
In plain wordsRead moreRead the paper on PubMed